Company Overview and News
40 of 104 Russell 3000 Index stocks were deemed "safer" for dividends because they showed positive one-year returns and free cash flow yields greater than their dividend yields.
ANH.PRA GEO GMRE.PRA ANH.PRC ANH.PRB ANH ORC LADR CIM GMRE CYS.PRA NYLD CLNS.PRDCL CYS.PRB CORR.PRA AGNC NYLD.A CORR CIM.PRA CLNS IVR.PRA IVR.PRB CLNS.PRJ CLNS.PRI IVR.PRC CLNS.PRH DX NLY GLPI NLY.PRA CLNS.PRG CLNS.PRE NLY.PRECL NLY.PRD CLNS.PRD NLY.PRE CIM.PRB CLNS.PRB CYS NLY.PRC NLY.PRF NLY.PRG IVR DX.PRB DX.PRA
Good morning. My name is Tiffany and I will be your conference operator today. At this time, I would like to welcome everyone to the FuelCell Energy's Second Quarter 2018 Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions] Thank you.
NRGEO HTGZ SOJA NRG SO NYLD FCELB HTGC NYLD.A HTGX FCEL HTGY
DANBURY, Conn., June 07, 2018 (GLOBE NEWSWIRE) -- FuelCell Energy, Inc. (Nasdaq:FCEL), a global leader in delivering clean, innovative and affordable fuel cell solutions for the supply, recovery and storage of energy, today reported financial results for the three and six-month periods ended April 30, 2018 and key business highlights.
NRGEO NRG NYLD FCELB NYLD.A FCEL
JE, SPKE, & SBS led the top ten WallStar Utilities per broker targeted price gains with combined 61.8% average net gains while 7 trailing combined for 24.5% average gains 5/23/18.
JE DUKH PEGI SCG SPKE AY DUK JE NYLD APU PPL PEG CAFD SPH NYLD.A JE.PRA TERP
Cheniere Energy (LNG) saw three upward target price revisions following its 1Q18 earnings. These changes could be due to an increase in its 2018 guidance.
TRP CQP CLMT LNG MS.PRE MS.PRF MS.PRG NEP MS.PRA MS.PRI MS.PRK NYLD CQH MS PLX NYLD.A
The S&P 500 headed slightly lower last week as a solid employment report on Friday helped the market recoup earlier losses. High expectations heading into earnings season, plus lingering trade war concerns and uncertainty over the Fed’s plans to raise rates, all weighed on sentiment. However, a handful of businesses added some good news with dividend increases.
SOHOL NYLD AAPL SOHOB SOHO CHCT TRTN NYLD.A SOHOM
Good day, ladies and gentlemen, and welcome to the NRG Yield First Quarter 2018 Earnings Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions]. As a reminder, this call is being recorded.
NRGEO NRG DB NYLD NYLD.A
6h - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
2018-07-13 - Asif
Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...
2018-07-09 - Asif
Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...
as of ET